CME vs PJT
CME Group vs PJT Partners Inc. — AI-powered side-by-side comparison
VS
PJT
PJT Partners Inc.
70
Buy
| Metric | CME | PJT |
|---|
| AI Score |
63
|
70
|
| Price |
$281.06
|
$174.38
|
| P/E Ratio |
23.40×
|
19.44×
|
| ROE |
14.1%
|
58.4%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
81.9%
|
64.6%
|
| Debt / Equity |
0.13×
|
1.34×
|
| Dividend Yield |
4.1%
|
0.6%
|
| RSI (14) |
68.7
|
54.8
|
| Beta |
0.267
|
0.828
|
| Expected Upside |
+3.7%
|
+6.0%
|
AI Committee View
Current Innellis committee reasoning for CME versus PJT.
PJT leads by 7 points.
PJT scores 70/100 (Buy) versus CME at 63/100 (Buy).
CME Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.12) -- balance sheet can absorb a shock. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 15.6% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
PJT Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 71.2% shows genuine earnings power backing the valuation — Value
- EPS growing 79.1% YoY — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
Bear Case
- Price-to-book of 26.4x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical